SlideShare a Scribd company logo
ISO-IMMUNE DISEASE
PRESENTED BY
MS. SANTOSH KUMARI
TERMINOLOGY
• Iso - immune – means immune disease
in which the antibodies are produced as
a result of antigens from another person.
• Autoimmune – in which the antigens
come from the same person.
Blood groups
•The differences in human blood are due to the
presence or absence of certain protein molecules
called antigens and antibodies.
•The antigens are located on the surface of the
RBCs and the antibodies are in the blood plasma.
•Individuals have different types and
combinations of these molecules.
•The blood group you belong to depends on what
you have inherited from your parents.
DIFFERENT BLOOD GROUPS
• There are more than 20 genetically determined
blood group systems known today
Eg. ABO System,Rh-System, MNS System, Kell
System, Lewis System
•The AB0 and Rhesus (Rh) systems are the most
important ones used for blood transfusions.
•Not all blood groups are compatible with each other.
Mixing incompatible blood groups leads to blood
clumping or agglutination, which is dangerous for
individuals.
Cont…
CLASSIFICATION OF BLOOD
GROUPS
Major Blood Grouping System:
 ABO blood group system
 Rh blood group system
 because they cause major transfusion reaction.
Minor Blood Grouping System:
 MNS blood group system
 p blood group system
 because they cause minor transfusion reaction.
Familial Blood Grouping System:
 Kell, Daffy, Lutheran, Lewis, Deigo, and Many
more.
According to the ABO blood
typing system there are four
different kinds of blood types: A,
B, AB or O (null).
ABO blood grouping system
Landsteiner Law
• It was given by Karl Landsteiner in 1900.
• It states that ; If an agglutinogen is
present on the RBC of an individual, the
corresponding agglutinin must be absent
in the plasma of that individual and vice-
versa.
• This law is only applicable to ABO blood
grouping system.
Blood group A
If you belong to the blood
group A, you have A
antigens on the surface of
your RBCs and B
antibodies in your blood
plasma.
Blood group B
If you belong to the blood
group B, you have B
antigens on the surface of
your RBCs and A
antibodies in your blood
plasma.
ABO BLOOD GROUPING SYSTEM
Blood group AB
If you belong to the blood group
AB, you have both A and B
antigens on the surface of your
RBCs and no A or B antibodies
at all in your blood plasma.
Blood group O
If you belong to the blood group O
(null), you have neither A or B
antigens on the surface of your RBCs
but you have both A and B antibodies
in your blood plasma.
View Of Different Cells And Antibodies
Blood
Group
Antigens Antibodies Can give
blood to
Can
receive
blood from
AB A and B None AB AB, A, B, O
A A B A and AB A and O
B B A B and AB B and O
O None A and B AB, A, B, O O
Blood group O is called
"universal donor"
because it has no antigens
on RBC.
Blood group AB are called
"universal
receivers“ because it has
no anti- bodies in the
plasma.
The Rhesus (Rh) System
• The Rhesus factor gets its name from
experiments conducted in 1937 by scientists
Karl Landsteiner and Alexander S. Weiner.
• Their experiments involved rabbits which,
when injected with the Rhesus monkey's red
blood cells, produced an antigen that is
present in the red blood cells of many
humans.
•The genotype is determined by the inheritance of 3
pairs of closely linked allelic genes situated on
chromosome 9 named as
D/d,
C/c,
E/e
……….. (Fisher- Race theory)
• A condition that occurs during pregnancy if
a blood and her
blood. Mother’s body create Rh
antibodies against the baby’s blood.
• Also known as haemolytic disease of the
fetus and newborn(HDFN).
Oct-15 18Rhesus Incompatibility
• First demonstrated in rhesus monkey
• Blood groups are classified as Rh
positive and Rh negative
• The Rh factor , Rh+ and Rh- usually refers
specifically to the presence or absence of antigen-
D
•There are two alleles, or genetic variants , of this
antigen: D and d.
•A person who is Rh- has two recessive traits, dd.
Anyone who has at least one D-DD or Dd-is Rh+
• A person's Rh type is generally most relevant
with respect to pregnancies
• If the pregnant woman and her husband are
Rh negative, there is no reason to worry about
Rh incompatibility
•If she is Rh negative and her husband is Rh
positive,the baby will inherit the father's blood
type ,creating incompatibility between mother
and her fetus.
•If some of the fetal blood gets into mother's
blood stream, her body will produce antibodies.
•These antibodies could pass back through the
placenta and harm the developing baby's red
blood cells, causing very mild to very serious
anemia in the fetus.
Pathogenesis
Oct-15 Rhesus Incompatibility 23
1. Rh-ve mother carrying Rh+ve
fetus
2. Entry of fetus Rh+ve RBC into
maternal circulation
3. Development of Rh antibodies
by the mother
• Usually placenta acts as barrier to fetal blood entering
maternal circulation. However, sometimes during
pregnancy or birth,fetomaternal haemorrhage (FMH)
can occur. The woman’s immune system reacts by
producing anti-D antibodies that cause sensitisation
•In subsequent pregnancies antibodies can cross placenta
and destroy fetal erythrocytes. The haemolytic disease of
fetus and new born caused by Rh isoimmunisation can
occur during the first pregnancy, but usually sensitisation
during the first pregnancy or birth leads to extensive
destruction of fetal RBC during subsequent pregnancies
Conditions which affects 1st pregnancy
are:
• Miscarriage
• Abortion
• Feto-maternal haemorrage
Sign &symptom of Rh incompatibility:
• Rh incompatibility can cause symptoms ranging
from very mild to fatal.
• Mildest form- Rh incompatibility:
1-Hemolysis (Destruction of the red blood cells)
with the release of free hemoglobin into the
infant's circulation.
2- Jaundice (Hemoglobin is converted into,bilirubin
which causes an infant to become yellow.
Fetal- hemolysis
Jaundice
Severe form- Rh
incompatibility
1- Hydrops fetalis (Massive fetal
red blood cell destruction).
2- It causes Severe
anemiaFetal heart
failure Death of the infant
shortly after delivery.
2- Total body swelling.
3- Respiratory distress (if the infant has been delivered)
4- Circulatory collapse.
5- Kernicterus. (Neurological syndrome in extremely
jaundiced infants)
6- It occurs several days after delivery and is
characterized initially by...
A) Loss of the Moro reflex.
B)Poor Feeding.
C) Decreased activity
LATER 
• At last it may lead to death of the child
immediately after its birth
1-There are no any physical symptoms can be seen
in rh incompatibility.
2-If the woman just found out she is pregnant,she
should undergo blood-type test. This test
determines her blood type and Rh factor.
3-Blood test that will determine whether she is Rh
positive or Rh negative
DETECTION OF Rh INCOMPATIBILITY:
Treatment
• Intrauterine transfusion
• Elect time of delivery
• Exchange transfusion after delivery
• Phototherapy after delivery
• Top-up transfusion
(Hb falls below 7g/dl, prophylactic :oral folate)
Oct-15 36Rhesus Incompatibility
Intrauterine transfusion
• The fetus can die in utero from severe anaemia
and hydrops before he can be delivered.
• An intrauterine transfusion can prolong the life
in utero of a fetus to a gestation where the risks
of prematurity are estimated as being less than
those of the Rh disease. This can be done by an:
1. Intraperitoneal transfusion guided by
ultrasound.
2. Umbilical vein transfusion guided by
ultrasound.
Oct-15 Rhesus Incompatibility 37
• Rh-negative blood is either transfused
under ultrasound control. Repeat as
necessary, according to amniotic optical
density, or fetal haematocrit. The
intravenous route is becoming increasingly
the preferred method.
Choose time of induction and best
method of delivery
• Balance the risks of prematurity (too soon) with
that of worsening Rh disease (too late).
• Consider the risks of vaginal delivery and be
prepared for a lower segment Caesarean section
(LSCS).
• Usually done only after 34 weeks of gestation.
• The paediatric team should be in close and a
senior paediatrician present at the delivery
• fresh Rh-negative blood available.
Oct-15 Rhesus Incompatibility 39
Resuscitation and Exchange transfusion
• Good resuscitation is
essential. In an anaemic.
premature infant, lung
disease is common. It can
be due to:
 Surfactant deficiency at
very early delivery.
 Pulmonary oedema from
anaemia and
hypoproteinaemia.
 Hypoplastic lungs
secondary to pleural
effusions.
• In severe Rh haemolytic
disease of the newborn, an
umbilical artery catheter
should be inserted as soon
as possible to assess and
control PaO2 and pH.
• Central venous pressure
should be measured.
 Drain pleural effusions and
ascites at resuscitation.
Oct-15 Rhesus Incompatibility 40
Indication for exchange
Transfusion:
1. Early: Decision mainly based
on cord haemoglobin
(in addition consider history of
previously affected babies).
• Cord haemoglobin <12g/dl.
• Strongly positive Coombs’
test.
• Cord bilirubin >85mmol/l.
2. Late: Usually done for
hyperbilirubinaemia.
• The aims:
 Treat anaemia.
 Washes out IgG antibodies.
 Decreases degree of
haemolysis.
 Removes bilirubin.
 Prevents kernicterus.
Oct-15 Rhesus Incompatibility 41
Resuscitation and Exchange transfusion
Phototherapy
• Placing newborn baby under a halogen or
fluorescent lamp with their eyes covered.
• Lowers the bilirubin levels in the baby’s blood
through photo-oxidation.
• During phototherapy, intravenous hydration is
required.
Oct-15 Rhesus Incompatibility 42
Phototherapy of neonatal jaundice
Prevention and Prophylaxis
• Anti-D immunoglobulin to all Rh-negative women
at 28 and 34 weeks routinely-RAADP Or give anti-
D immunoglobulin
if she has a:
 Therapeutic abortion.
Spontaneous abortion/ectopic pregnancy.
 Amniocentesis.
 Any bleeding in pregnancy/threatened miscarriage.
 External Cephalic Version.
 After delivery at any gestation within 72Hours.
Oct-15 44Rhesus Incompatibility
NURSING MANAGEMENT
DIAGNOSIS
Risk for injury from breaking down products of RBCs
in greater numbers than normal and functional
immaturity of the liver.
Goals
• Will receive appropriate therapy to accelerate
bilirubin excretion.
• Will experience no complications from phototherapy.
• Will experience no complications from exchange
transfusin.
• Interrupted family process R/T infant with
potentially adverse physiologic response.
• Family will receive emotional support.
• Family will be prepared for home care of the
neonate.
• NURSING CARE for Rh incompatibility DURING
PHOTOTHERAPY
1. Remove clothing to proper skin exposure.
2.Turn infant frequently to expose all skin area.
3. Record and report jaundice and blood levels of
bilirubin.
4. Record and report if any change in body
temperature
5. Cover and check eyes with eye patches to
prevent eye injury.
-Be sure the eyes close before applying eye patch
to prevent corneal irritation.
-Should be loose enough to avoid pressure.
-Eye patches should be changed every 8houly and
eye care given.
6.Nurse should expect the infant’s stools to be
green and the urine dark because of photo
degradation products.
7. Serum bilirubin and hematocrit should be
monitored during therapy and for 24 hours
following therapy.
8.In case of breast milk jaundice stop breast
feeding temporarily.
9. Maintain feeding intervals to prevent
dehydration.
Summary:
Oct-15 Rhesus Incompatibility 53
IUFD
Introduction
• In addition to cases in which a fetus dies during
delivery as a result of asphyxia (oxygen
deprivation if the umbilical cord becomes
twisted) or difficult labor.
• Others can die in utero before labor starts.
followed by expulsion of the fetus from the
uterus within a few days.
• However, in rare instances the dead fetus is not
expelled from the uterus at once, but is retained
for several weeks.
• Fetal death refers to the spontaneous death of
a fetus at any time during pregnancy, although
the term is often used interchangeably with
‘stillbirth’.
• A stillbirth is a death that occurs after 20
weeks of gestation.
Definition of IUFD
Intrauterine fetal death: is the clinical term for
the death of a baby in the uterus, during
pregnancy and before birth. The term is
usually used for pregnancy losses that
happen after the 20th week of gestation.
Epidemiology
•In the present investigation the epidemiological
factors responsible for intrauterine fetal deaths
after 20 week of gestation were studied.
•A retrospective study of 16882 pregnancies
registered and managed in the Department of
Obstetrics and Gynecology, in united state
Continue…..
One hundred and three cases of intrauterine
fetal deaths were registered and treated
expectantly out of 16882 total pregnancies
registered during the four year study period.
The stillbirth rate was 6.1 per 1000 total births.
Etiology
Pregnancy complications:
- Pre-eclamptic toxemia
- Antepartum haemorrhage : placenta previa,
abruptio placentae
Pre- existing medical disease and acute
illness:
- Chronic hypertension
- Chronic nephritis
- Diabetes
- Severe anemia
- Hyperpyrexia
- Syphilis, Hepatitis, toxoplasmosis etc.
Hyperpyrexia
Cont..
• Fetal
- Congenital malformation
- Rh-incompatibility
- Post maturity
• External version
• Idiopathic 20 –30%
Cont…
• Maternal Complications
• Decreased platelets
• Decreased fibrinogen
• Increased PT/PTT (Clotting times)
• Clinical bleeding / oozing from all sites
RX involves DELIVERY, pRBC’s, FFP, PLATELETS,
Supportive Management
Cont….
• Depression, Anxiety, Psychosocial
• Anxiety with future pregnancies
• May have repeat losses (depending on causes)
• Bleeding ---> can lead to DIC but may only
require blood product replacement
• Pain, Infection (similar to any other delivery)
Risk factors
•Multiple pregnancy
•Advanced maternal age
•History of fetal demise (IUFD)
•Maternal infertility
•Maternal haemoconcentration
•Maternal colonization with certain pathogens
•Small for gestational age infant
•Obesity
•Paternal age
•African American race
Clinical features
• Absence of fetal movement
• Vaginal bleeding
• Abdominal pain
• Small uterus than the duration of pregnancy
• Sometimes secretion of colostrum occur few
days after death of fetus in uterus.
Diagnosis of IUFD
• In most patients, the only symptom is decreased
fetal movement. An inability to obtain fetal heart
tones upon examination suggests fetal demise;
however, this is not diagnostic and death must be
confirmed by diagnostic tests .
• Labor should be induced as soon as possible after
diagnosis. Patient responses vary in regard to this
recommendation; some wish to begin induction
immediately, while others wish to delay induction
for a period of hours or days until they are
emotionally prepared.
Cont…
• Blood test because it comes negative within a
week after the death of the fetus.
• The secretion of estriol it is a type of estrogen
produced by an active placenta in the
mother’s urine falls sharply.
Treatment & management
• Explain the problem to the woman and her
family. Discuss with them the options of
expectant or active management.
• Medical induction of labor: Medicine is used
to start labor and fetus delivered naturally.
Pain management
• Pain management in patients undergoing
induction of labor for fetal death is usually easier
to manage than in patients with live fetuses.
• Higher doses of narcotics are available to the
patient and often a morphine is sufficient for
successful pain control. Should a patient desire
superior pain control to intravenous narcotics,
epidural anesthesia should be offered.
NURSING MANAGEMENT
Diagnosis
Anticipatory grieving related to fetal loss
Intervention
• To give the patient time to gather support
from her family and to fathom the reality of
the situation.
• Provide psychological support.
• Provide counseling to the mother as well as
family.
Nursing health care guidelines at home
• Teach the patient to be aware of the signs and
symptoms that could indicate postpartum
complications:
• Pain in the calf of the leg; increase in vaginal
bleeding; foul odor of vaginal discharge; fever;
burning with urination; persistent mood charge;
or a hard, reddened area on the breast.
• Explain that the patient should not have
intercourse or drive a car until after the
postpartum check.
• Encourage participation in a bereavement
support group, even if the patient and
significant other seem to be coping with the
loss.
• They may be able to help other couples cope.
IUGR
SGA IUGR
NORMAL FOETAL GROWTH
• Cellular hyperplasia
• Hyperplasia and hypertrophy
• Hypertrophy
STAGES
• Stage I (Hyperplasia)
- 4 to 20 weeks
- Rapid mitosis
- Increase of DNA content
Cont…
• Stage II (Hyperplasia & Hypertrophy)
- 20 to 28 weeks
- Declining mitosis.
- Increase in cell size.
Cont…
• Stage III ( Hypertrophy)
- 28 to 40 weeks
- Rapid increase in cell size.
- Rapid accumulation of fat, muscle and
connective tissue.
• 95% of fetal weight gain occurs during last 20
weeks of gestations.
CAUSES OF IUGR
• Maternal factors
• Fetal factors
• Placental factors
• Environmental factors
MATERNAL FACTORS
•Medical disease
•Malnutrition  BMI < 19 twice the risk of
IUGR
•Multiple pregnancy
•Smoking (460 gm < then none smoker)
Cont…
•Alcohol  12-fold increase risk of IUGR
•Drugs  Beta- Blockers(Atenolol in
second trimster, Anticoagulants,
Anticonvulsants( phenytoin)
•Hypoxemia
•Infections  UTI, Malaria, TB, Genital
Infections
Cont …
• Small stature/ low pre-pregnancy weight
• Teen pregnancy
• Primi gravida
• Grand multiparity
FETAL FACTORS
• A Chromosome Defect-
 In second trimester 20% SGA fetuses
have chromosomal abnormality
 Triploid is most common under 26 wks.
 Trisomy-18 is common after 26 wks .
 Other are 21(Down’s syndrome), 16, 13,
xo (turner’s syndrome).
Cont….
• Exposure to an infection-
• German measles (rubella), cytomegalovirus,
herpes simplex, tuberculosis, syphilis, or
toxoplasmosis, TB, Malaria, Parvo virus
Cont…
• birth defects
• (cardiovascular, renal, anencephally, limb
defect, etc).
• A primary disorder of bone or cartilage.
• A chronic lack of oxygen during development
(hypoxia
• Placenta or umbilical cord defects.
PLACENTAL FACTORS
• Uteroplacental Insufficiency Resulting
From -.
–Improper / inadequate trophoblastic
invasion and placentation in the first
trimester.
–Lateral insertion of placenta.
–Reduced maternal blood flow to the
placental bed.
Cont…
• Fetoplacetal Insufficiency Due To-.
–Vascular anomalies of placenta and cord.
–Decreased placental functioning mass-.
• Small placenta, abruptio placenta,
placenta previa, post term pregnancy
Normal & IUGR Newborn babies
Normal & IUGR
Placentas
Environmental Causes of IUGR
• High altitude - lower environmental oxygen
saturation
• Toxins
Types of IUGR
• Symmetric IUGR
(33 % of IUGR Infants)
• Asymmetric IUGR
(55 % of IUGR)
• Combined type IUGR
(12 % of IUGR)
SYMMETRICAL
• Height, weight, head circ proportional
• Early pregnancy insult:
• Commonly due to congenital infection, genetic
disorder, or intrinsic factors
• Reduced no of cells in fetus
• Normal ponderal index
• Low risk of perinatal asphyxia
• Low risk of hypoglycemia
PONDERAL INDEX
• The ponderal index is used determine those
infants whose soft tissue mass is below
normal for their stage of skeletal
development.
Ponderal Index = birth weight x 100
crown-heel length
Cont…
• Typical values are 20 to 25.
• Those who have a ponderal index below the
10th % can be classified as SGA
• PI is normal in symmetric IUGR.
• PI is low in asymmetric IUGR
ASSYMETRICAL
• Later in pregnancy:
• Commonly due to utero placental
insufficiency, maternal malnutrition, hypoxia,
or extrinsic factors
• Low ponderal index
• Cell number remains same but size is small
• Increased risk of asphyxia
• Increased risk of hypoglycemia
• Growth restriction in the stage of hypertrophy
• Brain sparing effect
• Head growth remains normal but abdominal
girth slows down
Newer Classification
1. Normal Small Fetuses-
• Have no structural abnormality, normal
umbilical artery & liquor but wt., is less.
• They are not at risk and do not need any special
care.
Abnormal Small Fetuses- have chromosomal
anomalies or structural malformations. They
are lost cases and deserve termination as
nothing can be done.
Growth Restricted Fetuses- are due to impaired
placental function. Appropriate & timely
treatment or termination can improve
prospects.
CLINICAL FEATURES
Weight deficit
Dry wrinkled skin
Large head circumference
Old man look
Cartilaginous ridges on pinna
Length remain unaffected
Open eyes
Thin umbilical cord
Well defined creases
Normal reflexes
Alert and active
Normal cry
• Scaphoid abdomen
• Signs of recent wasting
- soft tissue wasting
- diminished skin fold thickness
- decrease breast tissue
- reduced thigh circumference
• Signs of long term growth failure
- Widened skull sutures, large fontanelles
- shortened crown – heel length
- delayed development of epiphyses
DIAGNOSIS OF IUGR
• History
• Risk factors
• Last menstrual period - most precise size of
uterus
• Time of quickening (detection of fetal
movements)
• Examination
• Maternal serum screening
Uterine Artery Doppler Velocimetry
- Notching of the waveform /reduce EDF
associated 3-fold increase in risk of FGR.
• Combination of un-explain elevated maternal AFP
is powerful predictor of adverse perinatal
outcome (FGR)
• Increase AFP combine with echogenic bowel is
strong predictor of FGR
• DOPPLER OF THE UMBILICAL ARTERY
• Reduced end diastolic flow.
• Absent end diastolic flow
• Reversed end diastolic flow( severe cases)
Problems
• Hypoxia
- Perinatal asphyxia
- Persistent pulmonary hypertension
- meconium aspiration
• Thermoregulation
- Hypothermia due to diminished
subcutaneous fat and elevated
surface/volume ratio
Metabolic
- Hypoglycemia
- result from inadequate glycogen stores.
- diminished gluconeogenesis.
- increased BMR
- Hypocalcemia
- due to high serum glucagon level, which
stimulate calcitonin excretion
• Hematologic
- hyperviscosity and polycythemia due to
increase erythropoietin level sec. to hypoxia
• Immunologic
- IUGR have increased protein catabolism and
decreased in protein, prealbumin and
immunoglobulins, which decreased humoral
and cellular immunity.
• Fetal distress,
• Hypoxia, Acidosis and Low Apgar Score at
birth.
Increased perinatal morbidity and mortality
• Grade 3-4 intraventricular haemorrhage
• Necrotizing enterocolitis
• BIOPHYSICAL
• HC:AC
• Brfore 32 wks more than 1
• 32—34 wks app 1
• FEMUR LENGTH
• FL:AC IS 22at all gest wks from 21 wks to term
• More than 23.5 indicate IUGR
• AFI
• <2 Suggest IUGR
• PI
PREVENTION OF HYPOTHERMIA
• MUMMIFICATION
• KMC
• NESTING
• DELAY BATH
• WARMER
MAINTAINING BREATHING
• VENTILATOR
• C PAP
• 02 SUPPLEMENTATION
NUTRITION FLUID AND FEEDING
• <30– IV FLUIDS, NG ,KATORI, BREAST FEEDS
• 30—34 NG ,KATORI, BREAST FEEDS
• >34 KATORI, BREAST FEEDS
Monitoring
• Vital signs
• Activity and behaviour.
• Color; Pink, pale, grey, blue, yellow.
• Tissue perfusion
• Fluids, electrolytes and ABG's.
COMPLICATION
Cont…
• Bronchopulmonary dysplasia
• Metabolic disturbances and hypoglycemia
• Polycytemia
• Hypothermia
• Impaired cognitive function and cerebral
paresis
MEDICAL MANAGEMENT
• ASPIRIN THERAPY
• Other forms of treatment that have been
studied are
• nutritional supplementation,
• zinc supplementation,
• fish oil,
• hormones and
• oxygen therapy
NURSING MANAGEMENT (During Pregnancy)
Diagnosis
• Impaired nutritional status less then body
requirement related to malnutrition.
Intervention
• To correct malnutrition by providing balanced
diet.
• To take extra calories from normal i.e. 300
calories extra.
• To provide nutritious foods, juices, fruits etc.
Diagnosis
• Decreased uteroplacental circulation related
to reduced blood flow to maternal surface or
placental cause.
Intervention
• Adequate bed red in left lateral position.
• Provide low dose of aspirin i.e. 50 mg daily.
• Prove o2 to mother at the rate of 2.5 L/min by
nasal prong for short term for prolongation of
pregnancy.
Diagnosis
• Decreased knowledge status of mother
related to IUGR, its complication to baby.
Intervention
• Provide knowledge to the mother.
• Provide health education to mother related to
self care as well as related to diet.
• Provide detailed information about her
condition of baby as well as complication for
baby.
NURSING MANAGEMENT FOR BABY
Risk for infection related to poor immunity
Goal
Care at neonatal intensive care unit
Intervention
• The NICU should be warm, free from excessive sound
smoothing light.
• Protection from infection should be ensured by aseptic
measures and effective hand washing.
• Rough handling and painful procedure should be
avoided.
• Baby should be placed on soft comfortable, “nestled”
and cushioned bed.
• Continuous monitoring of the baby’s clinical status are
vital aspects.
Decreased body temperature related to IUGR
Goal
Maintenance of stable body temperature
Intervention
• Baby should be received in a pre warmed radiant
warmer or incubator. Environmental temperature
should be maintained according to baby’s weight
and age.
• Baby’s skin temperature should be maintained 36.5
to 37.5 degree celcious.
• Baby birth weight of less than 1200gm should be
cared in the NICU incubator with 60 to 70 %
humidity, oxygen and thermo nutral environment
for better thermal control and prevent heat loss.
Decreased body weight of baby related to IUGR.
Goal
Maintenance of nutrition and hydration
Intervention
• Caloric needs of non-growing LBW babies during first
week of life are 60 kcal/ kg/ day on 7th is to be
stepped up gradually to 100 on 14th day and about
120-150 on 21st day, to maintain satisfactory
growth.
• Human milk is the first choice of nutrition for all LBW
babies. Colostrums, hind milk, foremilk, and preterm
milk help faster growth of baby.
• If breast milk is not available cows milk in proportion
of 1:1 (milk: water) for 1st month and 2:1 during
second month is an alternative substitute.
CONCLUSION
AND
SUMMARY
RESEARCH ARTICLE
TITLE - Study of causes and complications of intra
uterine fetal death (IUFD)
OBJECTIVES - This study were to study the causes of
Intra Uterine Fetal Death (IUFD), associated
complications and to suggest preventive measures.
METHODS - Study design: retrospective observational
study. This study was carried out over a period of 3
months (April 2014- June 2014) at a tertiary care
hospital. Inclusion criteria was all IUFD >20 weeks of
gestation.
RESULT
Out of 1850 total births during the study period
80 IUFD occurred. Hence proportion of IUFD
was 4.3%. In this study, Still Birth Rate (SBR) as
per WHO criteria (28 weeks) was 22.1 per 1000.
Registered patients were 24 (30%) whereas 56
(70%) were emergency admissions. Majority of
cases, 48 (60%) were multigravidae with past
obstetric history of abortion and IUFD in 13
(16.2%) and 9 (11.2%) respectively. In 31
(38.7%) no identifiable cause of IUFD was found
whereas cause was identified in 49 (61.3%).
Conclusions
Anemia, PIH, accidental haemorrhage were
leading causes of IUFD. Majority of women
who had IUFD were emergency admission
who had not received adequate antenatal
care. A significant proportion of IUFD is
preventable by health education to patients
and community for regular antenatal care,
about warning signs during antenatal period,
hospital delivery and early referral.
Iso immune disease
Iso immune disease

More Related Content

What's hot

Pregnancy induced hypertension
Pregnancy induced hypertensionPregnancy induced hypertension
Pregnancy induced hypertension
Chetna Bhatt
 
Haemorrhagic Shock In Pregnancy
Haemorrhagic Shock In PregnancyHaemorrhagic Shock In Pregnancy
Haemorrhagic Shock In Pregnancy
jayatheeswaranvijayakumar
 
Rh incompatibility in pregnancy
Rh incompatibility in pregnancyRh incompatibility in pregnancy
Rh incompatibility in pregnancy
DR MUKESH SAH
 
Obstetrical shock
Obstetrical  shockObstetrical  shock
Obstetrical shockdrmcbansal
 
Obstructed labour
Obstructed labourObstructed labour
Obstructed labour
Naila Memon
 
Cpd & contracted pelvis
Cpd & contracted pelvisCpd & contracted pelvis
Cpd & contracted pelvis
SREEVIDYA UMMADISETTI
 
Premature labour
Premature labourPremature labour
Premature labour
Balkeej Sidhu
 
Shock in obstetrics
Shock in obstetricsShock in obstetrics
Shock in obstetrics
hemnathsubedii
 
Abnormal uterine action
Abnormal uterine actionAbnormal uterine action
Abnormal uterine action
Priyanka Gohil
 
Renal disease-in-pregnency
Renal disease-in-pregnencyRenal disease-in-pregnency
Renal disease-in-pregnency
FarragBahbah
 
Hepatitis and pregnangy
Hepatitis and pregnangyHepatitis and pregnangy
Hepatitis and pregnangy
Radwa Rasheedy
 
Rh negative disease
Rh negative diseaseRh negative disease
Rh negative disease
fitango
 
Amniotic fluid embolism
Amniotic fluid embolismAmniotic fluid embolism
Amniotic fluid embolism
Priti Patil
 
Hyperemesis gravidarum and its management
Hyperemesis gravidarum and its managementHyperemesis gravidarum and its management
Hyperemesis gravidarum and its management
sunil kumar daha
 
Placental circulation
Placental  circulationPlacental  circulation
Placental circulation
Abhilasha verma
 
Infection in pregnancy
Infection in pregnancyInfection in pregnancy
Infection in pregnancy
Fadzlina Zabri
 
Respiratory disorders in pregnancy
Respiratory disorders in pregnancyRespiratory disorders in pregnancy
Respiratory disorders in pregnancy
dr.hafsa asim
 
Rh Incompatibility I Hemolytic Disease of the Newborn
Rh Incompatibility I Hemolytic Disease of the NewbornRh Incompatibility I Hemolytic Disease of the Newborn
Rh Incompatibility I Hemolytic Disease of the Newborn
Swatilekha Das
 

What's hot (20)

Pregnancy induced hypertension
Pregnancy induced hypertensionPregnancy induced hypertension
Pregnancy induced hypertension
 
Haemorrhagic Shock In Pregnancy
Haemorrhagic Shock In PregnancyHaemorrhagic Shock In Pregnancy
Haemorrhagic Shock In Pregnancy
 
Rh incompatibility in pregnancy
Rh incompatibility in pregnancyRh incompatibility in pregnancy
Rh incompatibility in pregnancy
 
Obstetrical shock
Obstetrical  shockObstetrical  shock
Obstetrical shock
 
Obstructed labour
Obstructed labourObstructed labour
Obstructed labour
 
Cpd & contracted pelvis
Cpd & contracted pelvisCpd & contracted pelvis
Cpd & contracted pelvis
 
Premature labour
Premature labourPremature labour
Premature labour
 
Shock in obstetrics
Shock in obstetricsShock in obstetrics
Shock in obstetrics
 
Abnormal uterine action
Abnormal uterine actionAbnormal uterine action
Abnormal uterine action
 
Renal disease-in-pregnency
Renal disease-in-pregnencyRenal disease-in-pregnency
Renal disease-in-pregnency
 
Hepatitis and pregnangy
Hepatitis and pregnangyHepatitis and pregnangy
Hepatitis and pregnangy
 
Rh negative disease
Rh negative diseaseRh negative disease
Rh negative disease
 
Amniotic fluid embolism
Amniotic fluid embolismAmniotic fluid embolism
Amniotic fluid embolism
 
Hyperemesis gravidarum and its management
Hyperemesis gravidarum and its managementHyperemesis gravidarum and its management
Hyperemesis gravidarum and its management
 
Placental circulation
Placental  circulationPlacental  circulation
Placental circulation
 
Infection in pregnancy
Infection in pregnancyInfection in pregnancy
Infection in pregnancy
 
Respiratory disorders in pregnancy
Respiratory disorders in pregnancyRespiratory disorders in pregnancy
Respiratory disorders in pregnancy
 
Rh Incompatibility I Hemolytic Disease of the Newborn
Rh Incompatibility I Hemolytic Disease of the NewbornRh Incompatibility I Hemolytic Disease of the Newborn
Rh Incompatibility I Hemolytic Disease of the Newborn
 
Cardiac disease in pregnancy
Cardiac disease in pregnancyCardiac disease in pregnancy
Cardiac disease in pregnancy
 
Pre eclampsia
Pre eclampsiaPre eclampsia
Pre eclampsia
 

Viewers also liked

Immunologic tolerance
Immunologic toleranceImmunologic tolerance
Immunologic toleranceRobin Gulati
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
Lionel Wolberger
 
Tolerance Auto-immune Diseases and Tumor Immunity
Tolerance Auto-immune Diseases and Tumor ImmunityTolerance Auto-immune Diseases and Tumor Immunity
Tolerance Auto-immune Diseases and Tumor Immunity
Dr. Aamir Ali Khan
 
Pharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunityPharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunitymmoney1
 
Immune tolerance
Immune toleranceImmune tolerance
Immune tolerance
Jahidul ahsan
 
Cell Tolerance
Cell ToleranceCell Tolerance
Cell Tolerancehephz
 
Immunology xiii autoimmunity
Immunology xiii autoimmunityImmunology xiii autoimmunity
Immunology xiii autoimmunityMUBOSScz
 
Central immunological tolerance
Central immunological toleranceCentral immunological tolerance
Central immunological tolerance
Somen Mistri
 
Immunohematology basics
Immunohematology basicsImmunohematology basics
Immunohematology basics
SR MEDICAL COLLEGE VARKALA TRIVANDRUM
 
Immunological tolerance by Arad Boustan
Immunological tolerance by Arad BoustanImmunological tolerance by Arad Boustan
Immunological tolerance by Arad Boustan
Arad Boustan
 
Abo blood grp
Abo blood grpAbo blood grp
Abo blood grp
Niaz Ahammed
 
Kell blood group system
Kell blood group systemKell blood group system
Kell blood group system
Rafiq Ahmad
 
Blood group.007[1]
Blood group.007[1]Blood group.007[1]
Blood group.007[1]
Pallav Desai
 
Autoimmunity and autoimmune disease
Autoimmunity and autoimmune diseaseAutoimmunity and autoimmune disease
Autoimmunity and autoimmune disease
Rhondene Wint
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
Yahya Noori, Ph.D
 
Hypersensitivity, Tolerance and autoimmunity
Hypersensitivity, Tolerance and autoimmunityHypersensitivity, Tolerance and autoimmunity
Hypersensitivity, Tolerance and autoimmunity
Yahya Noori, Ph.D
 
Tolerance & autoimmunity
Tolerance & autoimmunityTolerance & autoimmunity
Tolerance & autoimmunityOmar Moatamed
 

Viewers also liked (20)

Helminthes Use In Treatment Of Autoimmune Disease
Helminthes Use In Treatment Of Autoimmune DiseaseHelminthes Use In Treatment Of Autoimmune Disease
Helminthes Use In Treatment Of Autoimmune Disease
 
Immunologic tolerance
Immunologic toleranceImmunologic tolerance
Immunologic tolerance
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Tolerance Auto-immune Diseases and Tumor Immunity
Tolerance Auto-immune Diseases and Tumor ImmunityTolerance Auto-immune Diseases and Tumor Immunity
Tolerance Auto-immune Diseases and Tumor Immunity
 
Pharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunityPharm immuno12 &13 tolerance & autoimmunity
Pharm immuno12 &13 tolerance & autoimmunity
 
Immune tolerance
Immune toleranceImmune tolerance
Immune tolerance
 
Cell Tolerance
Cell ToleranceCell Tolerance
Cell Tolerance
 
Immunology xiii autoimmunity
Immunology xiii autoimmunityImmunology xiii autoimmunity
Immunology xiii autoimmunity
 
Central immunological tolerance
Central immunological toleranceCentral immunological tolerance
Central immunological tolerance
 
Immunohematology basics
Immunohematology basicsImmunohematology basics
Immunohematology basics
 
Immunological tolerance by Arad Boustan
Immunological tolerance by Arad BoustanImmunological tolerance by Arad Boustan
Immunological tolerance by Arad Boustan
 
Abo blood grp
Abo blood grpAbo blood grp
Abo blood grp
 
Kell blood group system
Kell blood group systemKell blood group system
Kell blood group system
 
Blood group.007[1]
Blood group.007[1]Blood group.007[1]
Blood group.007[1]
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Autoimmunity and autoimmune disease
Autoimmunity and autoimmune diseaseAutoimmunity and autoimmune disease
Autoimmunity and autoimmune disease
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Hypersensitivity, Tolerance and autoimmunity
Hypersensitivity, Tolerance and autoimmunityHypersensitivity, Tolerance and autoimmunity
Hypersensitivity, Tolerance and autoimmunity
 
Tolerance & autoimmunity
Tolerance & autoimmunityTolerance & autoimmunity
Tolerance & autoimmunity
 

Similar to Iso immune disease

ISO IMMUNE DISEASE.pptx
ISO IMMUNE DISEASE.pptxISO IMMUNE DISEASE.pptx
ISO IMMUNE DISEASE.pptx
SANCHAYEETA2
 
Lecture 27- Blood Group.pptx
Lecture 27- Blood Group.pptxLecture 27- Blood Group.pptx
Lecture 27- Blood Group.pptx
DineshVeera5
 
Rh factor
Rh factorRh factor
Rh factor
Nihal Yuzbasheva
 
Blood grouping
Blood grouping Blood grouping
Blood grouping
MynameisHabib1
 
Blood Types and Blood Transfusion.pdf
Blood Types and Blood Transfusion.pdfBlood Types and Blood Transfusion.pdf
Blood Types and Blood Transfusion.pdf
GiaPhongVu1
 
Blood group and typing 2021
Blood group and typing 2021Blood group and typing 2021
Blood group and typing 2021
Dr Shamshad Begum loni
 
Blood Grouping.pptx
Blood Grouping.pptxBlood Grouping.pptx
Blood Grouping.pptx
PrasanthThalur
 
Blood groups,blood transfusion,hazards,blood bank
Blood groups,blood transfusion,hazards,blood bankBlood groups,blood transfusion,hazards,blood bank
Blood groups,blood transfusion,hazards,blood bank
Ranadhi Das
 
Blood Group system & Hemolytic Disease of New born
Blood Group system & Hemolytic Disease of New bornBlood Group system & Hemolytic Disease of New born
Blood Group system & Hemolytic Disease of New born
Praveen Kumar
 
1569612387419 physiology[1]
1569612387419 physiology[1]1569612387419 physiology[1]
1569612387419 physiology[1]
SanaYaseen8
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
Amith W A
 
Document (17).pdf
Document (17).pdfDocument (17).pdf
Document (17).pdf
AmmaraKhan49
 
2. Blood Groups, Rh incompatibility,blood transfusion reactions
2. Blood Groups, Rh incompatibility,blood transfusion reactions2. Blood Groups, Rh incompatibility,blood transfusion reactions
2. Blood Groups, Rh incompatibility,blood transfusion reactions
sanaakram65
 
Blood grouping and their significance
Blood grouping and  their significanceBlood grouping and  their significance
Blood grouping and their significance
Amjad Afridi
 
RH ISOIMMUNIZATION BWIRE2.pptx
RH ISOIMMUNIZATION BWIRE2.pptxRH ISOIMMUNIZATION BWIRE2.pptx
RH ISOIMMUNIZATION BWIRE2.pptx
bwire innocent
 
Blood group and typing
Blood group and typing Blood group and typing
Blood group and typing
Dr Shamshad Begum loni
 

Similar to Iso immune disease (20)

ISO IMMUNE DISEASE.pptx
ISO IMMUNE DISEASE.pptxISO IMMUNE DISEASE.pptx
ISO IMMUNE DISEASE.pptx
 
Rh incompatibility
Rh incompatibilityRh incompatibility
Rh incompatibility
 
Lecture 27- Blood Group.pptx
Lecture 27- Blood Group.pptxLecture 27- Blood Group.pptx
Lecture 27- Blood Group.pptx
 
Blood group
Blood groupBlood group
Blood group
 
Blood group
Blood groupBlood group
Blood group
 
Blood group
Blood groupBlood group
Blood group
 
Rh factor
Rh factorRh factor
Rh factor
 
Blood grouping
Blood grouping Blood grouping
Blood grouping
 
Blood Types and Blood Transfusion.pdf
Blood Types and Blood Transfusion.pdfBlood Types and Blood Transfusion.pdf
Blood Types and Blood Transfusion.pdf
 
Blood group and typing 2021
Blood group and typing 2021Blood group and typing 2021
Blood group and typing 2021
 
Blood Grouping.pptx
Blood Grouping.pptxBlood Grouping.pptx
Blood Grouping.pptx
 
Blood groups,blood transfusion,hazards,blood bank
Blood groups,blood transfusion,hazards,blood bankBlood groups,blood transfusion,hazards,blood bank
Blood groups,blood transfusion,hazards,blood bank
 
Blood Group system & Hemolytic Disease of New born
Blood Group system & Hemolytic Disease of New bornBlood Group system & Hemolytic Disease of New born
Blood Group system & Hemolytic Disease of New born
 
1569612387419 physiology[1]
1569612387419 physiology[1]1569612387419 physiology[1]
1569612387419 physiology[1]
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Document (17).pdf
Document (17).pdfDocument (17).pdf
Document (17).pdf
 
2. Blood Groups, Rh incompatibility,blood transfusion reactions
2. Blood Groups, Rh incompatibility,blood transfusion reactions2. Blood Groups, Rh incompatibility,blood transfusion reactions
2. Blood Groups, Rh incompatibility,blood transfusion reactions
 
Blood grouping and their significance
Blood grouping and  their significanceBlood grouping and  their significance
Blood grouping and their significance
 
RH ISOIMMUNIZATION BWIRE2.pptx
RH ISOIMMUNIZATION BWIRE2.pptxRH ISOIMMUNIZATION BWIRE2.pptx
RH ISOIMMUNIZATION BWIRE2.pptx
 
Blood group and typing
Blood group and typing Blood group and typing
Blood group and typing
 

More from Santosh Kumari

Genetic development and anatomy of female reproductive organs
Genetic development and anatomy of female reproductive organsGenetic development and anatomy of female reproductive organs
Genetic development and anatomy of female reproductive organs
Santosh Kumari
 
Infertility
Infertility Infertility
Infertility
Santosh Kumari
 
Lactation
LactationLactation
Lactation
Santosh Kumari
 
Preconceptional care
Preconceptional carePreconceptional care
Preconceptional care
Santosh Kumari
 
Project method
Project methodProject method
Project method
Santosh Kumari
 
Reproductive tract anomalies
Reproductive tract anomaliesReproductive tract anomalies
Reproductive tract anomalies
Santosh Kumari
 
Seminar on pert
Seminar on pertSeminar on pert
Seminar on pert
Santosh Kumari
 
Antihypertensive and Anticonvulsant drugs in OBG
Antihypertensive and Anticonvulsant drugs in OBGAntihypertensive and Anticonvulsant drugs in OBG
Antihypertensive and Anticonvulsant drugs in OBG
Santosh Kumari
 
WHO partograph
WHO partographWHO partograph
WHO partograph
Santosh Kumari
 
Urinary System
Urinary SystemUrinary System
Urinary System
Santosh Kumari
 

More from Santosh Kumari (11)

Genetic development and anatomy of female reproductive organs
Genetic development and anatomy of female reproductive organsGenetic development and anatomy of female reproductive organs
Genetic development and anatomy of female reproductive organs
 
Infertility
Infertility Infertility
Infertility
 
Lactation
LactationLactation
Lactation
 
Preconceptional care
Preconceptional carePreconceptional care
Preconceptional care
 
Project method
Project methodProject method
Project method
 
Reproductive tract anomalies
Reproductive tract anomaliesReproductive tract anomalies
Reproductive tract anomalies
 
Hrt
HrtHrt
Hrt
 
Seminar on pert
Seminar on pertSeminar on pert
Seminar on pert
 
Antihypertensive and Anticonvulsant drugs in OBG
Antihypertensive and Anticonvulsant drugs in OBGAntihypertensive and Anticonvulsant drugs in OBG
Antihypertensive and Anticonvulsant drugs in OBG
 
WHO partograph
WHO partographWHO partograph
WHO partograph
 
Urinary System
Urinary SystemUrinary System
Urinary System
 

Recently uploaded

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 

Recently uploaded (20)

special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 

Iso immune disease

  • 1.
  • 3. TERMINOLOGY • Iso - immune – means immune disease in which the antibodies are produced as a result of antigens from another person. • Autoimmune – in which the antigens come from the same person.
  • 5. •The differences in human blood are due to the presence or absence of certain protein molecules called antigens and antibodies. •The antigens are located on the surface of the RBCs and the antibodies are in the blood plasma. •Individuals have different types and combinations of these molecules. •The blood group you belong to depends on what you have inherited from your parents. DIFFERENT BLOOD GROUPS
  • 6. • There are more than 20 genetically determined blood group systems known today Eg. ABO System,Rh-System, MNS System, Kell System, Lewis System •The AB0 and Rhesus (Rh) systems are the most important ones used for blood transfusions. •Not all blood groups are compatible with each other. Mixing incompatible blood groups leads to blood clumping or agglutination, which is dangerous for individuals. Cont…
  • 7. CLASSIFICATION OF BLOOD GROUPS Major Blood Grouping System:  ABO blood group system  Rh blood group system  because they cause major transfusion reaction. Minor Blood Grouping System:  MNS blood group system  p blood group system  because they cause minor transfusion reaction. Familial Blood Grouping System:  Kell, Daffy, Lutheran, Lewis, Deigo, and Many more.
  • 8. According to the ABO blood typing system there are four different kinds of blood types: A, B, AB or O (null). ABO blood grouping system
  • 9. Landsteiner Law • It was given by Karl Landsteiner in 1900. • It states that ; If an agglutinogen is present on the RBC of an individual, the corresponding agglutinin must be absent in the plasma of that individual and vice- versa. • This law is only applicable to ABO blood grouping system.
  • 10. Blood group A If you belong to the blood group A, you have A antigens on the surface of your RBCs and B antibodies in your blood plasma. Blood group B If you belong to the blood group B, you have B antigens on the surface of your RBCs and A antibodies in your blood plasma. ABO BLOOD GROUPING SYSTEM
  • 11. Blood group AB If you belong to the blood group AB, you have both A and B antigens on the surface of your RBCs and no A or B antibodies at all in your blood plasma. Blood group O If you belong to the blood group O (null), you have neither A or B antigens on the surface of your RBCs but you have both A and B antibodies in your blood plasma.
  • 12. View Of Different Cells And Antibodies
  • 13. Blood Group Antigens Antibodies Can give blood to Can receive blood from AB A and B None AB AB, A, B, O A A B A and AB A and O B B A B and AB B and O O None A and B AB, A, B, O O
  • 14. Blood group O is called "universal donor" because it has no antigens on RBC. Blood group AB are called "universal receivers“ because it has no anti- bodies in the plasma.
  • 15. The Rhesus (Rh) System
  • 16. • The Rhesus factor gets its name from experiments conducted in 1937 by scientists Karl Landsteiner and Alexander S. Weiner. • Their experiments involved rabbits which, when injected with the Rhesus monkey's red blood cells, produced an antigen that is present in the red blood cells of many humans.
  • 17. •The genotype is determined by the inheritance of 3 pairs of closely linked allelic genes situated on chromosome 9 named as D/d, C/c, E/e ……….. (Fisher- Race theory)
  • 18. • A condition that occurs during pregnancy if a blood and her blood. Mother’s body create Rh antibodies against the baby’s blood. • Also known as haemolytic disease of the fetus and newborn(HDFN). Oct-15 18Rhesus Incompatibility
  • 19. • First demonstrated in rhesus monkey • Blood groups are classified as Rh positive and Rh negative
  • 20. • The Rh factor , Rh+ and Rh- usually refers specifically to the presence or absence of antigen- D •There are two alleles, or genetic variants , of this antigen: D and d. •A person who is Rh- has two recessive traits, dd. Anyone who has at least one D-DD or Dd-is Rh+
  • 21. • A person's Rh type is generally most relevant with respect to pregnancies • If the pregnant woman and her husband are Rh negative, there is no reason to worry about Rh incompatibility
  • 22. •If she is Rh negative and her husband is Rh positive,the baby will inherit the father's blood type ,creating incompatibility between mother and her fetus. •If some of the fetal blood gets into mother's blood stream, her body will produce antibodies. •These antibodies could pass back through the placenta and harm the developing baby's red blood cells, causing very mild to very serious anemia in the fetus.
  • 23. Pathogenesis Oct-15 Rhesus Incompatibility 23 1. Rh-ve mother carrying Rh+ve fetus 2. Entry of fetus Rh+ve RBC into maternal circulation 3. Development of Rh antibodies by the mother
  • 24. • Usually placenta acts as barrier to fetal blood entering maternal circulation. However, sometimes during pregnancy or birth,fetomaternal haemorrhage (FMH) can occur. The woman’s immune system reacts by producing anti-D antibodies that cause sensitisation
  • 25.
  • 26. •In subsequent pregnancies antibodies can cross placenta and destroy fetal erythrocytes. The haemolytic disease of fetus and new born caused by Rh isoimmunisation can occur during the first pregnancy, but usually sensitisation during the first pregnancy or birth leads to extensive destruction of fetal RBC during subsequent pregnancies
  • 27. Conditions which affects 1st pregnancy are: • Miscarriage • Abortion • Feto-maternal haemorrage
  • 28. Sign &symptom of Rh incompatibility: • Rh incompatibility can cause symptoms ranging from very mild to fatal. • Mildest form- Rh incompatibility: 1-Hemolysis (Destruction of the red blood cells) with the release of free hemoglobin into the infant's circulation. 2- Jaundice (Hemoglobin is converted into,bilirubin which causes an infant to become yellow.
  • 31. Severe form- Rh incompatibility 1- Hydrops fetalis (Massive fetal red blood cell destruction). 2- It causes Severe anemiaFetal heart failure Death of the infant shortly after delivery.
  • 32. 2- Total body swelling. 3- Respiratory distress (if the infant has been delivered) 4- Circulatory collapse. 5- Kernicterus. (Neurological syndrome in extremely jaundiced infants) 6- It occurs several days after delivery and is characterized initially by... A) Loss of the Moro reflex. B)Poor Feeding. C) Decreased activity
  • 33. LATER  • At last it may lead to death of the child immediately after its birth
  • 34.
  • 35. 1-There are no any physical symptoms can be seen in rh incompatibility. 2-If the woman just found out she is pregnant,she should undergo blood-type test. This test determines her blood type and Rh factor. 3-Blood test that will determine whether she is Rh positive or Rh negative DETECTION OF Rh INCOMPATIBILITY:
  • 36. Treatment • Intrauterine transfusion • Elect time of delivery • Exchange transfusion after delivery • Phototherapy after delivery • Top-up transfusion (Hb falls below 7g/dl, prophylactic :oral folate) Oct-15 36Rhesus Incompatibility
  • 37. Intrauterine transfusion • The fetus can die in utero from severe anaemia and hydrops before he can be delivered. • An intrauterine transfusion can prolong the life in utero of a fetus to a gestation where the risks of prematurity are estimated as being less than those of the Rh disease. This can be done by an: 1. Intraperitoneal transfusion guided by ultrasound. 2. Umbilical vein transfusion guided by ultrasound. Oct-15 Rhesus Incompatibility 37
  • 38. • Rh-negative blood is either transfused under ultrasound control. Repeat as necessary, according to amniotic optical density, or fetal haematocrit. The intravenous route is becoming increasingly the preferred method.
  • 39. Choose time of induction and best method of delivery • Balance the risks of prematurity (too soon) with that of worsening Rh disease (too late). • Consider the risks of vaginal delivery and be prepared for a lower segment Caesarean section (LSCS). • Usually done only after 34 weeks of gestation. • The paediatric team should be in close and a senior paediatrician present at the delivery • fresh Rh-negative blood available. Oct-15 Rhesus Incompatibility 39
  • 40. Resuscitation and Exchange transfusion • Good resuscitation is essential. In an anaemic. premature infant, lung disease is common. It can be due to:  Surfactant deficiency at very early delivery.  Pulmonary oedema from anaemia and hypoproteinaemia.  Hypoplastic lungs secondary to pleural effusions. • In severe Rh haemolytic disease of the newborn, an umbilical artery catheter should be inserted as soon as possible to assess and control PaO2 and pH. • Central venous pressure should be measured.  Drain pleural effusions and ascites at resuscitation. Oct-15 Rhesus Incompatibility 40
  • 41. Indication for exchange Transfusion: 1. Early: Decision mainly based on cord haemoglobin (in addition consider history of previously affected babies). • Cord haemoglobin <12g/dl. • Strongly positive Coombs’ test. • Cord bilirubin >85mmol/l. 2. Late: Usually done for hyperbilirubinaemia. • The aims:  Treat anaemia.  Washes out IgG antibodies.  Decreases degree of haemolysis.  Removes bilirubin.  Prevents kernicterus. Oct-15 Rhesus Incompatibility 41 Resuscitation and Exchange transfusion
  • 42. Phototherapy • Placing newborn baby under a halogen or fluorescent lamp with their eyes covered. • Lowers the bilirubin levels in the baby’s blood through photo-oxidation. • During phototherapy, intravenous hydration is required. Oct-15 Rhesus Incompatibility 42
  • 44. Prevention and Prophylaxis • Anti-D immunoglobulin to all Rh-negative women at 28 and 34 weeks routinely-RAADP Or give anti- D immunoglobulin if she has a:  Therapeutic abortion. Spontaneous abortion/ectopic pregnancy.  Amniocentesis.  Any bleeding in pregnancy/threatened miscarriage.  External Cephalic Version.  After delivery at any gestation within 72Hours. Oct-15 44Rhesus Incompatibility
  • 45. NURSING MANAGEMENT DIAGNOSIS Risk for injury from breaking down products of RBCs in greater numbers than normal and functional immaturity of the liver. Goals • Will receive appropriate therapy to accelerate bilirubin excretion. • Will experience no complications from phototherapy. • Will experience no complications from exchange transfusin.
  • 46. • Interrupted family process R/T infant with potentially adverse physiologic response. • Family will receive emotional support. • Family will be prepared for home care of the neonate.
  • 47. • NURSING CARE for Rh incompatibility DURING PHOTOTHERAPY 1. Remove clothing to proper skin exposure. 2.Turn infant frequently to expose all skin area. 3. Record and report jaundice and blood levels of bilirubin. 4. Record and report if any change in body temperature
  • 48. 5. Cover and check eyes with eye patches to prevent eye injury. -Be sure the eyes close before applying eye patch to prevent corneal irritation. -Should be loose enough to avoid pressure. -Eye patches should be changed every 8houly and eye care given. 6.Nurse should expect the infant’s stools to be green and the urine dark because of photo degradation products.
  • 49. 7. Serum bilirubin and hematocrit should be monitored during therapy and for 24 hours following therapy. 8.In case of breast milk jaundice stop breast feeding temporarily. 9. Maintain feeding intervals to prevent dehydration.
  • 51.
  • 52.
  • 54. IUFD
  • 55. Introduction • In addition to cases in which a fetus dies during delivery as a result of asphyxia (oxygen deprivation if the umbilical cord becomes twisted) or difficult labor. • Others can die in utero before labor starts. followed by expulsion of the fetus from the uterus within a few days. • However, in rare instances the dead fetus is not expelled from the uterus at once, but is retained for several weeks.
  • 56. • Fetal death refers to the spontaneous death of a fetus at any time during pregnancy, although the term is often used interchangeably with ‘stillbirth’. • A stillbirth is a death that occurs after 20 weeks of gestation.
  • 57. Definition of IUFD Intrauterine fetal death: is the clinical term for the death of a baby in the uterus, during pregnancy and before birth. The term is usually used for pregnancy losses that happen after the 20th week of gestation.
  • 58. Epidemiology •In the present investigation the epidemiological factors responsible for intrauterine fetal deaths after 20 week of gestation were studied. •A retrospective study of 16882 pregnancies registered and managed in the Department of Obstetrics and Gynecology, in united state
  • 59. Continue….. One hundred and three cases of intrauterine fetal deaths were registered and treated expectantly out of 16882 total pregnancies registered during the four year study period. The stillbirth rate was 6.1 per 1000 total births.
  • 60. Etiology Pregnancy complications: - Pre-eclamptic toxemia - Antepartum haemorrhage : placenta previa, abruptio placentae Pre- existing medical disease and acute illness: - Chronic hypertension - Chronic nephritis - Diabetes - Severe anemia - Hyperpyrexia - Syphilis, Hepatitis, toxoplasmosis etc. Hyperpyrexia
  • 61. Cont.. • Fetal - Congenital malformation - Rh-incompatibility - Post maturity • External version • Idiopathic 20 –30%
  • 62. Cont… • Maternal Complications • Decreased platelets • Decreased fibrinogen • Increased PT/PTT (Clotting times) • Clinical bleeding / oozing from all sites RX involves DELIVERY, pRBC’s, FFP, PLATELETS, Supportive Management
  • 63. Cont…. • Depression, Anxiety, Psychosocial • Anxiety with future pregnancies • May have repeat losses (depending on causes) • Bleeding ---> can lead to DIC but may only require blood product replacement • Pain, Infection (similar to any other delivery)
  • 64. Risk factors •Multiple pregnancy •Advanced maternal age •History of fetal demise (IUFD) •Maternal infertility •Maternal haemoconcentration •Maternal colonization with certain pathogens •Small for gestational age infant •Obesity •Paternal age •African American race
  • 65. Clinical features • Absence of fetal movement • Vaginal bleeding • Abdominal pain • Small uterus than the duration of pregnancy • Sometimes secretion of colostrum occur few days after death of fetus in uterus.
  • 66. Diagnosis of IUFD • In most patients, the only symptom is decreased fetal movement. An inability to obtain fetal heart tones upon examination suggests fetal demise; however, this is not diagnostic and death must be confirmed by diagnostic tests . • Labor should be induced as soon as possible after diagnosis. Patient responses vary in regard to this recommendation; some wish to begin induction immediately, while others wish to delay induction for a period of hours or days until they are emotionally prepared.
  • 68. • Blood test because it comes negative within a week after the death of the fetus. • The secretion of estriol it is a type of estrogen produced by an active placenta in the mother’s urine falls sharply.
  • 69. Treatment & management • Explain the problem to the woman and her family. Discuss with them the options of expectant or active management. • Medical induction of labor: Medicine is used to start labor and fetus delivered naturally.
  • 70.
  • 71. Pain management • Pain management in patients undergoing induction of labor for fetal death is usually easier to manage than in patients with live fetuses. • Higher doses of narcotics are available to the patient and often a morphine is sufficient for successful pain control. Should a patient desire superior pain control to intravenous narcotics, epidural anesthesia should be offered.
  • 72.
  • 73. NURSING MANAGEMENT Diagnosis Anticipatory grieving related to fetal loss Intervention • To give the patient time to gather support from her family and to fathom the reality of the situation. • Provide psychological support. • Provide counseling to the mother as well as family.
  • 74. Nursing health care guidelines at home • Teach the patient to be aware of the signs and symptoms that could indicate postpartum complications: • Pain in the calf of the leg; increase in vaginal bleeding; foul odor of vaginal discharge; fever; burning with urination; persistent mood charge; or a hard, reddened area on the breast.
  • 75. • Explain that the patient should not have intercourse or drive a car until after the postpartum check. • Encourage participation in a bereavement support group, even if the patient and significant other seem to be coping with the loss. • They may be able to help other couples cope.
  • 76. IUGR
  • 77.
  • 78.
  • 80. NORMAL FOETAL GROWTH • Cellular hyperplasia • Hyperplasia and hypertrophy • Hypertrophy
  • 81. STAGES • Stage I (Hyperplasia) - 4 to 20 weeks - Rapid mitosis - Increase of DNA content
  • 82. Cont… • Stage II (Hyperplasia & Hypertrophy) - 20 to 28 weeks - Declining mitosis. - Increase in cell size.
  • 83. Cont… • Stage III ( Hypertrophy) - 28 to 40 weeks - Rapid increase in cell size. - Rapid accumulation of fat, muscle and connective tissue. • 95% of fetal weight gain occurs during last 20 weeks of gestations.
  • 84. CAUSES OF IUGR • Maternal factors • Fetal factors • Placental factors • Environmental factors
  • 85. MATERNAL FACTORS •Medical disease •Malnutrition  BMI < 19 twice the risk of IUGR •Multiple pregnancy •Smoking (460 gm < then none smoker)
  • 86. Cont… •Alcohol  12-fold increase risk of IUGR •Drugs  Beta- Blockers(Atenolol in second trimster, Anticoagulants, Anticonvulsants( phenytoin) •Hypoxemia •Infections  UTI, Malaria, TB, Genital Infections
  • 87. Cont … • Small stature/ low pre-pregnancy weight • Teen pregnancy • Primi gravida • Grand multiparity
  • 88. FETAL FACTORS • A Chromosome Defect-  In second trimester 20% SGA fetuses have chromosomal abnormality  Triploid is most common under 26 wks.  Trisomy-18 is common after 26 wks .  Other are 21(Down’s syndrome), 16, 13, xo (turner’s syndrome).
  • 89. Cont…. • Exposure to an infection- • German measles (rubella), cytomegalovirus, herpes simplex, tuberculosis, syphilis, or toxoplasmosis, TB, Malaria, Parvo virus
  • 90. Cont… • birth defects • (cardiovascular, renal, anencephally, limb defect, etc). • A primary disorder of bone or cartilage. • A chronic lack of oxygen during development (hypoxia • Placenta or umbilical cord defects.
  • 91. PLACENTAL FACTORS • Uteroplacental Insufficiency Resulting From -. –Improper / inadequate trophoblastic invasion and placentation in the first trimester. –Lateral insertion of placenta. –Reduced maternal blood flow to the placental bed.
  • 92. Cont… • Fetoplacetal Insufficiency Due To-. –Vascular anomalies of placenta and cord. –Decreased placental functioning mass-. • Small placenta, abruptio placenta, placenta previa, post term pregnancy
  • 93. Normal & IUGR Newborn babies
  • 95. Environmental Causes of IUGR • High altitude - lower environmental oxygen saturation • Toxins
  • 96. Types of IUGR • Symmetric IUGR (33 % of IUGR Infants) • Asymmetric IUGR (55 % of IUGR) • Combined type IUGR (12 % of IUGR)
  • 97. SYMMETRICAL • Height, weight, head circ proportional • Early pregnancy insult: • Commonly due to congenital infection, genetic disorder, or intrinsic factors • Reduced no of cells in fetus • Normal ponderal index • Low risk of perinatal asphyxia • Low risk of hypoglycemia
  • 98. PONDERAL INDEX • The ponderal index is used determine those infants whose soft tissue mass is below normal for their stage of skeletal development. Ponderal Index = birth weight x 100 crown-heel length
  • 99. Cont… • Typical values are 20 to 25. • Those who have a ponderal index below the 10th % can be classified as SGA • PI is normal in symmetric IUGR. • PI is low in asymmetric IUGR
  • 100. ASSYMETRICAL • Later in pregnancy: • Commonly due to utero placental insufficiency, maternal malnutrition, hypoxia, or extrinsic factors • Low ponderal index • Cell number remains same but size is small • Increased risk of asphyxia • Increased risk of hypoglycemia
  • 101. • Growth restriction in the stage of hypertrophy • Brain sparing effect • Head growth remains normal but abdominal girth slows down
  • 102.
  • 103.
  • 104.
  • 105. Newer Classification 1. Normal Small Fetuses- • Have no structural abnormality, normal umbilical artery & liquor but wt., is less. • They are not at risk and do not need any special care.
  • 106. Abnormal Small Fetuses- have chromosomal anomalies or structural malformations. They are lost cases and deserve termination as nothing can be done. Growth Restricted Fetuses- are due to impaired placental function. Appropriate & timely treatment or termination can improve prospects.
  • 108. Weight deficit Dry wrinkled skin Large head circumference Old man look Cartilaginous ridges on pinna
  • 109. Length remain unaffected Open eyes Thin umbilical cord Well defined creases Normal reflexes Alert and active Normal cry
  • 111. • Signs of recent wasting - soft tissue wasting - diminished skin fold thickness - decrease breast tissue - reduced thigh circumference • Signs of long term growth failure - Widened skull sutures, large fontanelles - shortened crown – heel length - delayed development of epiphyses
  • 112. DIAGNOSIS OF IUGR • History • Risk factors • Last menstrual period - most precise size of uterus • Time of quickening (detection of fetal movements) • Examination • Maternal serum screening
  • 113. Uterine Artery Doppler Velocimetry - Notching of the waveform /reduce EDF associated 3-fold increase in risk of FGR. • Combination of un-explain elevated maternal AFP is powerful predictor of adverse perinatal outcome (FGR) • Increase AFP combine with echogenic bowel is strong predictor of FGR
  • 114. • DOPPLER OF THE UMBILICAL ARTERY • Reduced end diastolic flow. • Absent end diastolic flow • Reversed end diastolic flow( severe cases)
  • 115.
  • 116.
  • 117.
  • 118. Problems • Hypoxia - Perinatal asphyxia - Persistent pulmonary hypertension - meconium aspiration • Thermoregulation - Hypothermia due to diminished subcutaneous fat and elevated surface/volume ratio
  • 119. Metabolic - Hypoglycemia - result from inadequate glycogen stores. - diminished gluconeogenesis. - increased BMR - Hypocalcemia - due to high serum glucagon level, which stimulate calcitonin excretion
  • 120. • Hematologic - hyperviscosity and polycythemia due to increase erythropoietin level sec. to hypoxia • Immunologic - IUGR have increased protein catabolism and decreased in protein, prealbumin and immunoglobulins, which decreased humoral and cellular immunity.
  • 121. • Fetal distress, • Hypoxia, Acidosis and Low Apgar Score at birth. Increased perinatal morbidity and mortality • Grade 3-4 intraventricular haemorrhage • Necrotizing enterocolitis
  • 122. • BIOPHYSICAL • HC:AC • Brfore 32 wks more than 1 • 32—34 wks app 1 • FEMUR LENGTH • FL:AC IS 22at all gest wks from 21 wks to term • More than 23.5 indicate IUGR
  • 123. • AFI • <2 Suggest IUGR • PI
  • 124. PREVENTION OF HYPOTHERMIA • MUMMIFICATION • KMC • NESTING • DELAY BATH • WARMER
  • 125. MAINTAINING BREATHING • VENTILATOR • C PAP • 02 SUPPLEMENTATION
  • 126. NUTRITION FLUID AND FEEDING • <30– IV FLUIDS, NG ,KATORI, BREAST FEEDS • 30—34 NG ,KATORI, BREAST FEEDS • >34 KATORI, BREAST FEEDS
  • 127. Monitoring • Vital signs • Activity and behaviour. • Color; Pink, pale, grey, blue, yellow. • Tissue perfusion • Fluids, electrolytes and ABG's.
  • 130. • Bronchopulmonary dysplasia • Metabolic disturbances and hypoglycemia • Polycytemia • Hypothermia • Impaired cognitive function and cerebral paresis
  • 131. MEDICAL MANAGEMENT • ASPIRIN THERAPY • Other forms of treatment that have been studied are • nutritional supplementation, • zinc supplementation, • fish oil, • hormones and • oxygen therapy
  • 132. NURSING MANAGEMENT (During Pregnancy) Diagnosis • Impaired nutritional status less then body requirement related to malnutrition. Intervention • To correct malnutrition by providing balanced diet. • To take extra calories from normal i.e. 300 calories extra. • To provide nutritious foods, juices, fruits etc.
  • 133. Diagnosis • Decreased uteroplacental circulation related to reduced blood flow to maternal surface or placental cause. Intervention • Adequate bed red in left lateral position. • Provide low dose of aspirin i.e. 50 mg daily. • Prove o2 to mother at the rate of 2.5 L/min by nasal prong for short term for prolongation of pregnancy.
  • 134. Diagnosis • Decreased knowledge status of mother related to IUGR, its complication to baby. Intervention • Provide knowledge to the mother. • Provide health education to mother related to self care as well as related to diet. • Provide detailed information about her condition of baby as well as complication for baby.
  • 135. NURSING MANAGEMENT FOR BABY Risk for infection related to poor immunity Goal Care at neonatal intensive care unit Intervention • The NICU should be warm, free from excessive sound smoothing light. • Protection from infection should be ensured by aseptic measures and effective hand washing. • Rough handling and painful procedure should be avoided. • Baby should be placed on soft comfortable, “nestled” and cushioned bed. • Continuous monitoring of the baby’s clinical status are vital aspects.
  • 136. Decreased body temperature related to IUGR Goal Maintenance of stable body temperature Intervention • Baby should be received in a pre warmed radiant warmer or incubator. Environmental temperature should be maintained according to baby’s weight and age. • Baby’s skin temperature should be maintained 36.5 to 37.5 degree celcious. • Baby birth weight of less than 1200gm should be cared in the NICU incubator with 60 to 70 % humidity, oxygen and thermo nutral environment for better thermal control and prevent heat loss.
  • 137. Decreased body weight of baby related to IUGR. Goal Maintenance of nutrition and hydration Intervention • Caloric needs of non-growing LBW babies during first week of life are 60 kcal/ kg/ day on 7th is to be stepped up gradually to 100 on 14th day and about 120-150 on 21st day, to maintain satisfactory growth. • Human milk is the first choice of nutrition for all LBW babies. Colostrums, hind milk, foremilk, and preterm milk help faster growth of baby. • If breast milk is not available cows milk in proportion of 1:1 (milk: water) for 1st month and 2:1 during second month is an alternative substitute.
  • 139. RESEARCH ARTICLE TITLE - Study of causes and complications of intra uterine fetal death (IUFD) OBJECTIVES - This study were to study the causes of Intra Uterine Fetal Death (IUFD), associated complications and to suggest preventive measures. METHODS - Study design: retrospective observational study. This study was carried out over a period of 3 months (April 2014- June 2014) at a tertiary care hospital. Inclusion criteria was all IUFD >20 weeks of gestation.
  • 140. RESULT Out of 1850 total births during the study period 80 IUFD occurred. Hence proportion of IUFD was 4.3%. In this study, Still Birth Rate (SBR) as per WHO criteria (28 weeks) was 22.1 per 1000. Registered patients were 24 (30%) whereas 56 (70%) were emergency admissions. Majority of cases, 48 (60%) were multigravidae with past obstetric history of abortion and IUFD in 13 (16.2%) and 9 (11.2%) respectively. In 31 (38.7%) no identifiable cause of IUFD was found whereas cause was identified in 49 (61.3%).
  • 141. Conclusions Anemia, PIH, accidental haemorrhage were leading causes of IUFD. Majority of women who had IUFD were emergency admission who had not received adequate antenatal care. A significant proportion of IUFD is preventable by health education to patients and community for regular antenatal care, about warning signs during antenatal period, hospital delivery and early referral.

Editor's Notes

  1. Rhesus disease gets worse with successive pregnancies.
  2. Anti-D is given as prophylaxis and is useless once sensitization has occurred.